| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |